These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 5878160

  • 1. [Fibrinolysis and factors of aspecific immunity. Preliminary note].
    Ferrauto A, Giuffrida G, Terranova R.
    Boll Soc Ital Biol Sper; 1965 Dec 31; 41(24):1488-91. PubMed ID: 5878160
    [No Abstract] [Full Text] [Related]

  • 2. The complement system of man. I.
    Ruddy S, Gigli I, Austen KF.
    N Engl J Med; 1972 Sep 07; 287(10):489-95. PubMed ID: 4114930
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Quantitative studies on the properdin-complement system. II. Kinetics of the reaction between properdin and zymosan.
    LEON MA.
    J Exp Med; 1957 May 01; 105(5):403-15. PubMed ID: 13428911
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Aspecific immunity].
    Fiandino G.
    Minerva Pediatr; 1968 Sep 15; 20(37):1891-905. PubMed ID: 5745826
    [No Abstract] [Full Text] [Related]

  • 7. The rabbit properdin system: I. Identification of a new factor and purification of rabbit properdin.
    Naff GB, Hedrick SW, Ratnoff WD, Novak MA, Smith MC, Steiner C, Todd EW.
    J Immunol; 1980 Jun 15; 124(6):2625-31. PubMed ID: 6900053
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Mouse protection studies with zymosan vaccines and properdin sera. Contribution to unspecified immunity (resistance)].
    ZIMMERMANN G.
    Acta Biol Med Ger; 1962 Jun 15; 9():412-27. PubMed ID: 14003718
    [No Abstract] [Full Text] [Related]

  • 10. [Comparative studies on humoral factors of natural immunity of Phocaena phocaena].
    Luk'ianenko VI.
    Zh Obshch Biol; 1965 Jun 15; 26(3):373-4. PubMed ID: 5886608
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Research on the properdin system. I. Inactivation of the third complement component through zymosan on inulin.
    HEISE ER.
    Klin Wochenschr; 1958 Jan 15; 36(2):88-9. PubMed ID: 13540126
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [ON THE INCREASE OF ASPECIFIC IMMUNITY IN RELATION TO THE USE OF LYSOZYME AND ITS TOLERANCE IN INFANTS].
    DECICCO N, ROLANDO P, LEONARDI L.
    Pediatria (Napoli); 1964 Jun 30; 72():493-512. PubMed ID: 14170508
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibitor of human C3 associated with preparations of C3 dissociated from C3-zymosan complex.
    Blum L.
    J Immunol; 1969 Nov 30; 103(5):1116-24. PubMed ID: 5350971
    [No Abstract] [Full Text] [Related]

  • 19. The properdin system and immunity. XI. Studies on the interaction of zymosan with the properdin system.
    BLUM L, PILLEMER L, LEPOW IH.
    Z Immun exp ther; 1959 Nov 30; 118():313-28. PubMed ID: 13801695
    [No Abstract] [Full Text] [Related]

  • 20. [Experimental data on the interrelationship between certain factors of natural and acquired immunity in elevated environmental temperature].
    Karavanskaia NA.
    Gig Sanit; 1968 Oct 30; 33(10):24-8. PubMed ID: 5731753
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.